Testing effectiveness (Phase 2)Looking for participantsNCT07448038
What this trial is testing
Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Who this might be right for
Atherosclerosis
Genentech, Inc. 162